Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) stock analysis
HRMY · Harmony Biosciences Holdings, Inc. - Common Stock
Latest recorded price: USD 32.96
Model-estimated fair value: USD 99.27. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Biotechnology
At $32.96, HRMY trades 66.8% below the model's base-case value of $99.27. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $77.44 in the conservative case and $125.44 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 25.6%, free cash flow margin 40.1%, ROIC 66.4%. The model does not flag any risk signals for this company.